Epigenetic mechanism associated with clinical outcome and therapeutic vulnerability in liver cancer
Researchers at the Josep Carreras Leukemia Research Institute, led by Dr. Manel Esteller, have discovered a key epigenetic alteration that anticipates the clinical course of liver cancer. This is the deactivation of the NSUN7 ...
May 16, 2023
0
3